Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/19/2025

Diagnosis and Evaluation of Amyloidosis

Introduction to Amyloidosis Diagnosis

  • The American College of Cardiology recommends that the definitive diagnosis of amyloidosis requires tissue biopsy showing amyloid deposits with Congo red staining demonstrating apple-green birefringence under polarized light, followed by typing to determine the specific amyloid protein 1

Diagnostic Testing

  • Serum and urine testing for monoclonal proteins, including serum and urine immunofixation electrophoresis and serum free light chain assay, is recommended for the diagnosis of amyloidosis 2, 3
  • Cardiac biomarkers, such as NT-proBNP (elevated >332 ng/L has >99% sensitivity for cardiac involvement) and Troponin T/I/high-sensitivity troponin, can support the diagnosis of cardiac amyloidosis 1

Imaging Studies

  • Echocardiography can help diagnose cardiac amyloidosis by looking for LV wall thickness >12 mm, relative apical sparing on longitudinal strain, grade 2 or higher diastolic dysfunction, granular sparkling appearance of myocardium, and biatrial enlargement 1, 4
  • Cardiac MRI can also diagnose cardiac amyloidosis by looking for diffuse subendocardial or transmural late gadolinium enhancement, global extracellular volume >0.40, and abnormal gadolinium kinetics (myocardial nulling prior to blood pool) 1
  • Bone scintigraphy (if no monoclonal proteins detected) using 99mTc-PYP/DPD/HMDP nuclear imaging can suggest ATTR amyloidosis with grade 2-3 myocardial uptake 2, 3

Non-Biopsy Diagnosis Pathway

  • A non-biopsy diagnosis pathway can be used if all criteria are met, including grade 2-3 myocardial uptake on bone scintigraphy, absence of monoclonal protein on serum/urine testing, and typical cardiac imaging features 1, 2

Genetic Testing and Tissue Biopsy

  • Genetic testing, such as TTR gene sequencing, can differentiate hereditary variant from wild-type ATTR 2, 3
  • Tissue biopsy from an affected organ, minor salivary gland, abdominal fat pad aspiration, bone marrow, or rectal mucosa can confirm the diagnosis of amyloidosis 1, 5

Red Flags and Pitfalls

  • Red flags for cardiac amyloidosis include heart failure with preserved ejection fraction, intolerance to ACE inhibitors or beta blockers, bilateral carpal tunnel syndrome, lumbar spinal stenosis, biceps tendon rupture, and unexplained peripheral neuropathy 4
  • Pitfalls in diagnosis include relying solely on echocardiography without confirmatory testing, failing to exclude monoclonal gammopathy before diagnosing ATTR by bone scan, misinterpreting low-grade uptake on bone scintigraphy, and delaying diagnosis 4